Pyxis Oncology (PYXS) Interest & Investment Income (2020 - 2025)
Pyxis Oncology (PYXS) reported Interest & Investment Income of $590000.0 for Q4 2025, up 578.16% year-over-year from $87000.0 in Q4 2024, and down 26.25% quarter-over-quarter from $800000.0 in Q3 2025.
Pyxis Oncology (PYXS) Interest & Investment Income (2020 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 6 years of Interest & Investment Income data on file, last reported at $590000.0 in Q4 2025.
- Interest & Investment Income for Q4 2025 came in at $590000.0, up 578.16% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.6 million (up 42.98% YoY), and the FY2025 annual result was $3.6 million, up 287.1% from the prior year.
- Interest & Investment Income slipped to $590000.0 in Q4 2025 per PYXS's latest filing, from $800000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.9 million in Q4 2022 and troughed at $4000.0 in Q1 2021.
- A 5-year average of $748600.0 and a median of $654500.0 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2024: Interest & Investment Income soared 26642.86% in 2022, then tumbled 94.54% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $7000.0 in 2021, then soared by 26642.86% to $1.9 million in 2022, then retreated by 14.85% to $1.6 million in 2023, then plunged by 94.54% to $87000.0 in 2024, then surged by 578.16% to $590000.0 in 2025.
- Business Quant data shows PYXS's Interest & Investment Income at $590000.0 in Q4 2025, $800000.0 in Q3 2025, and $995000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Pyxis Oncology | 125.84 Mn | 108.95 Mn | 8.65 Mn | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 590,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 995,000.00 |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 262,000.00 |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 719,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 4,000.00 |